Ontario Drug System Reform

April 12, 2010

Tags:

Advertising and Marketing Food and Drug Regulatory Intellectual Property Life Sciences Pharmaceuticals

Related Expertise

Related Insights

CUSMA: Canadian patent applications to be eligible for patent term adjustment for unreasonable prosecution delays
Québec Superior Court decision could broaden the federal government’s scope over patented drug pricing
Examining the State of Drug Importation and Drug Pricing
Drug pricing and reimbursement: The role of provinces and hospitals in pharmaceutical pricing
Drug pricing and reimbursement: Federal drug price control

Back